Article Versions Notes

Polidoro S, Johansson H, Cugliari G, Guerrieri-Gonzaga A, Aristarco V, Macis D, Calvello M, Marabelli M, Feroce I, Serrano D, et al. Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study. Cancers. 2025; 17(19):3132. https://doi.org/10.3390/cancers17193132

Polidoro, Silvia, Harriet Johansson, Giovanni Cugliari, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Debora Macis, Mariarosaria Calvello, Monica Marabelli, Irene Feroce, Davide Serrano, and et al. 2025. "Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study" Cancers 17, no. 19: 3132. https://doi.org/10.3390/cancers17193132

Polidoro, S., Johansson, H., Cugliari, G., Guerrieri-Gonzaga, A., Aristarco, V., Macis, D., Calvello, M., Marabelli, M., Feroce, I., Serrano, D., Cagnacci, S., Zanzottera, C., Fava, F., Bellerba, F., Bonanni, B., & Gandini, S. (2025). Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study. Cancers, 17(19), 3132. https://doi.org/10.3390/cancers17193132